BOUNCE BIOMEDICAL LIMITED
Significant control: Orthox Holdings Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Bounce Biomedical Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Bounce Biomedical Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
BOUNCE BIOMEDICAL LIMITED is an active private limited company (company number 06606448) incorporated on 30 May 2008, registered in Abingdon. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 28 February 2026, showing net assets of −£2.45m and cash of £1.34m, with 3 employees on average. Net assets fell 28% on the prior period (−£1.91m).
By net assets it sits in the bottom quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
Ownership and control
- Orthox Holdings Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 30 May 200818 yrs ago
- Next accounts due
- 28 November 2027in 400 days
- Confirmation statement due
- 13 June 2027in 232 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2026 | −£2.45m | £1.34m | £128k | £1.44m | — | — | 3 |
| 28 February 2025 | −£1.91m | £350k | £123k | £1.44m | — | — | 3 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-2,446,542 at 28 February 2026
- Net assets down 25% or more on the prior period-27.8% vs prior period
- Cash at bank of £50,000 or moreCash £1,340,068
- Incorporated five or more years agoIncorporated 30 May 2008
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 400 days
- Confirmation statement duein 232 days
- Accounts period endNet liabilities £2.45m · small accounts
- Accounts period endNet liabilities £1.91m · small accounts
- Incorporated
Similar companies in Oxford
- TRIALMEDICA LIMITEDThame · inc. Feb 2008
- SONICHEM TECHNOLOGIES LIMITEDThame · inc. Dec 2007
- DISCUVA LIMITEDAbingdon · inc. Mar 2007
- MCC+R&D CONSULTING LIMITEDThame · inc. Dec 2009
- MATOKE HOLDINGS LIMITEDSouthmoor · inc. Feb 2010
- IG INNOVATIONS LIMITEDAbingdon · inc. Mar 2010
All companies incorporated on 30 May 2008 · in May 2008.
Reminders for BOUNCE BIOMEDICAL LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.